Literature DB >> 8409465

Human natural killer cells: a convenient purification procedure and the influence of cryopreservation on cytotoxic activity.

H Voshol1, H F Dullens, W Den Otter, J F Vliegenthart.   

Abstract

The recognition of natural killer cells as a lymphoid subpopulation with a distinct set of surface markers has led to the development of a variety of antibody-based purification methods. In this paper we describe a rapid, three-step negative selection protocol for the purification of human natural killer (NK) cells from the mononuclear cell fraction, which is obtained by the centrifugation of peripheral blood on Ficoll-Paque. Subsequently, monocytes and B lymphocytes are removed by adherence to nylon wool and T lymphocytes by panning with anti-CD3. With this procedure, CD3-, CD16/56+ NK cells are purified about five-fold, from 12 +/- 3% in the starting population to a final purity of 61 +/- 11%. A further increase to > or = 70% is obtained, if an extra Ficoll centrifugation step is included. The recovery of NK cells (50%) is significantly higher than is usually achieved by previously described procedures. Furthermore, we show that activation of cytotoxicity, with concomitant changes in target specificity, occurs when frozen/thawed NK effector cells are kept in culture in order to regain their pre-freezing cytotoxicity levels.

Entities:  

Mesh:

Year:  1993        PMID: 8409465     DOI: 10.1016/0022-1759(93)90102-d

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  9 in total

Review 1.  Generation of natural killer cells from hematopoietic stem cells in vitro for immunotherapy.

Authors:  Martha Luevano; Alejandro Madrigal; Aurore Saudemont
Journal:  Cell Mol Immunol       Date:  2012-06-18       Impact factor: 11.530

Review 2.  The Next Generation of Cellular Immunotherapy: Chimeric Antigen Receptor-Natural Killer Cells.

Authors:  Jake Moscarelli; David Zahavi; Rachael Maynard; Louis M Weiner
Journal:  Transplant Cell Ther       Date:  2022-07-03

3.  Defective expression and modulation of B7-2/CD86 on B cells in B cell chronic lymphocytic leukemia.

Authors:  Zhen-sheng Dai; Qin-fen Chen; Hong-zhou Lu; Yi Xie
Journal:  Int J Hematol       Date:  2009-05-09       Impact factor: 2.490

4.  Analysis of ex vivo expanded and activated clinical-grade human NK cells after cryopreservation.

Authors:  Sudarshawn N Damodharan; Kirsti L Walker; Matthew H Forsberg; Kimberly A McDowell; Myriam N Bouchlaka; Diana A Drier; Paul M Sondel; Kenneth B DeSantes; Christian M Capitini
Journal:  Cytotherapy       Date:  2020-06-11       Impact factor: 5.414

Review 5.  Validation of biomarkers to predict response to immunotherapy in cancer: Volume I - pre-analytical and analytical validation.

Authors:  Giuseppe V Masucci; Alessandra Cesano; Rachael Hawtin; Sylvia Janetzki; Jenny Zhang; Ilan Kirsch; Kevin K Dobbin; John Alvarez; Paul B Robbins; Senthamil R Selvan; Howard Z Streicher; Lisa H Butterfield; Magdalena Thurin
Journal:  J Immunother Cancer       Date:  2016-11-15       Impact factor: 13.751

Review 6.  Chimeric Antigen Receptor Expressing Natural Killer Cells for the Immunotherapy of Cancer.

Authors:  Rohtesh S Mehta; Katayoun Rezvani
Journal:  Front Immunol       Date:  2018-02-15       Impact factor: 7.561

7.  Cryopreservation impairs 3-D migration and cytotoxicity of natural killer cells.

Authors:  Christoph Mark; Tina Czerwinski; Susanne Roessner; Astrid Mainka; Franziska Hörsch; Lucas Heublein; Alexander Winterl; Sebastian Sanokowski; Sebastian Richter; Nina Bauer; Thomas E Angelini; Gerold Schuler; Ben Fabry; Caroline J Voskens
Journal:  Nat Commun       Date:  2020-10-16       Impact factor: 14.919

Review 8.  Chimeric antigen receptor natural killer (CAR-NK) cell design and engineering for cancer therapy.

Authors:  Ying Gong; Roel G J Klein Wolterink; Jianxiang Wang; Gerard M J Bos; Wilfred T V Germeraad
Journal:  J Hematol Oncol       Date:  2021-05-01       Impact factor: 17.388

9.  Cryopreserved PM21-Particle-Expanded Natural Killer Cells Maintain Cytotoxicity and Effector Functions In Vitro and In Vivo.

Authors:  Jeremiah L Oyer; Tayler J Croom-Perez; Thomas A Dieffenthaller; Liza D Robles-Carillo; Sarah B Gitto; Deborah A Altomare; Alicja J Copik
Journal:  Front Immunol       Date:  2022-04-07       Impact factor: 8.786

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.